Donor Lymphocyte Infusion May Reduce the Incidence of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 8, 2011, Pages 1214-1221

  Forslöw, Ulrica ^a   Mattsson, Jonas ^a   Gustafsson, Thomas ^a   Remberger, Mats ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bronchiolitis obliterans; HSCT; Spirometry

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT VERSUS HOST DISEASE; DONOR; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GRAFT VERSUS HOST REACTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; LYMPHOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RADIOGRAPHY; RISK FACTOR; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; BLOOD DONORS; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960240280     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.701     Document Type: Article

References (45)

1. Afessa B., Litzow M.R., Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 28:425-434.
2. Kotloff R.M., Ahya V.N., Crawford S.W. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004, 170:22-48.
3. Bergeron A., Belle A., Chevret S., et al. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2007, 39:547-553.
4. Forslow U., Mattsson J., Ringden O., Klominek J., Remberger M. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation. Scand J Infect Dis 2006, 38:970-976.
5. Ryu J.H., Myers J.L., Swensen S.J. Bronchiolar disorders. Am J Respir Crit Care Med 2003, 168:1277-1292.
6. Holland H.K., Wingard J.R., Beschorner W.E., Saral R., Santos G.W. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988, 72:621-627.
7. Clark J.G., Crawford S.W., Madtes D.K., Sullivan K.M. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989, 111:368-376.
8. Schultz K.R., Green G.J., Wensley D., et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994, 84:3212-3220.
9. Marras T.K., Chan C.K., Lipton J.H., Messner H.A., Szalai J.P., Laupacis A. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004, 33:509-517.
10. Yousem S.A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995, 26:668-675.
11. Estenne M., Hertz M.I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002, 166:440-444.
12. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
13. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
14. Uzunel M., Remberger M., Sairafi D., et al. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Transplantation 2006, 82:913-919.
15. Remberger M., Svahn B.M., Hentschke P., Lofgren C., Ringden O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant 1999, 24:823-830.
16. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
17. Lee S.J., Vogelsang G., Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003, 9:215-233.
18. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003, 168:208-214.
19. Ooi G.C., Peh W.C., Ip M. High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation. Respiration 1998, 65:187-191.
20. Markopoulo K.D., Cool C.D., Elliot T.L., et al. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J 2002, 19:20-30.
21. Lee E.S., Gotway M.B., Reddy G.P., Golden J.A., Keith F.M., Webb W.R. Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis. Radiology 2000, 216:472-477.
22. White D.A., Wong P.W., Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000, 161(3 Pt 1):723-729.
23. Suzuki T., Saijo Y., Ebina M., et al. Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant 1999, 23:829-831.
24. Soubani A.O., Uberti J.P. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 2007, 29:1007-1019.
25. Freudenberger T.D., Madtes D.K., Curtis J.R., Cummings P., Storer B.E., Hackman R.C. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003, 102:3822-3828.
26. Chang A.B., Masel J.P., Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol 1998, 28:23-29.
27. Penn C.C., Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993, 14:645-654.
28. Erard V., Chien J.W., Kim H.W., et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 2006, 193:1619-1625.
29. Philit F., Wiesendanger T., Archimbaud E., Mornex J.F., Brune J., Cordier J.F. Post-transplant obstructive lung disease (" bronchiolitis obliterans" ): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995, 8:551-558.
30. Patterson G.M., Wilson S., Whang J.L., et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996, 15:175-181.
31. Reynaud-Gaubert M., Thomas P., Badier M., Cau P., Giudicelli R., Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000, 161:1924-1929.
32. Ouwens J.P., van der Mark T.W., Koeter G.H., de Boer W.J., Grevink R.G., van der Bij W. Bronchiolar airflow impairment after lung transplantation: an early and common manifestation. J Heart Lung Transplant 2002, 21:1056-1061.
33. Payne L., Chan C.K., Fyles G., et al. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. Chest 1993, 104:114-118.
34. Yoshihara S., Tateishi U., Ando T., et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005, 35:1195-1200.
35. Johnson B.A., Iacono A.T., Zeevi A., McCurry K.R., Duncan S.R. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003, 167:1271-1278.
36. Gerhardt S.G., McDyer J.F., Girgis R.E., Conte J.V., Yang S.C., Orens J.B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003, 168:121-125.
37. Maimon N., Lipton J.H., Chan C.K., Marras T.K. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients. Bone Marrow Transplant 2009, 44:69-73.
38. Dudek A.Z., Mahaseth H., DeFor T.E., Weisdorf D.J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657-666.
39. Nishio N., Yagasaki H., Takahashi Y., et al. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2009, 44:303-308.
40. Storek J., Geddes M., Khan F., et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008, 30:425-437.
41. Clark J.G., Schwartz D.A., Flournoy N., Sullivan K.M., Crawford S.W., Thomas E.D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987, 107:648-656.
42. Ringden O., Remberger M., Ruutu T., et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999, 93:2196-2201.
43. Santo Tomas L.H., Loberiza F.R., Klein J.P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005, 128:153-161.
44. Dvorak C.C., Gilman A.L., Horn B., et al. Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions. Bone Marrow Transplant 2009, 4:805-812.
45. Mattsson J., Remberger M., Andersson O., Sundberg B., Nord M. Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 2005, 79:1411-1416.